back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-08-20 20:19 Tx date 2024-08-20 |
$WERX
FintechWerx International Software Services Inc. |
Carasquero, Francisco Kent
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Stanlark Ventures Inc. (Indirect Ownership)
|
Warrants
37 - Stock split or consolidation
|
-540,000 vol |
60,000 | |
| Filed 2024-08-20 20:16 Tx date 2024-08-20 |
$WERX
FintechWerx International Software Services Inc. |
Carasquero, Francisco Kent
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Stanlark Ventures Inc. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-1,687,500 vol |
187,500 | |
| Filed 2024-08-20 20:15 Tx date 2024-08-20 |
$WERX
FintechWerx International Software Services Inc. |
Carasquero, Francisco Kent
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Looking Glass Media Limited (Indirect Ownership)
|
Common Shares
36 - Conversion or exchange
|
-5,040,090 vol |
560,010 | |
| Filed 2024-08-02 19:57 Tx date 2024-07-31 |
$WERX
FintechWerx International Software Services Inc. |
Carasquero, Francisco Kent
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Looking Glass Media Limited (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$392,000
+5,600,000 vol $0.07 each |
5,600,100 | |
| Filed 2024-03-25 18:38 Tx date 2024-03-21 |
$NARA
Pangenomic Health Inc. |
Carasquero, Francisco Kent
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-571,480 vol |
63,498 | |
| Filed 2024-03-25 18:37 Tx date 2024-03-21 |
$NARA
Pangenomic Health Inc. |
Carasquero, Francisco Kent
4 - Director of Issuer
Holder: Stanlark Ventures Inc. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-594,000 vol |
66,000 | |
| Filed 2024-03-25 18:36 Tx date 2024-03-21 |
$NARA
Pangenomic Health Inc. |
Carasquero, Francisco Kent
4 - Director of Issuer
Holder: ETC3 Holdings Inc. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-360,000 vol |
40,000 | |
| Filed 2024-03-19 12:25 Tx date 2024-02-15 |
$NARA
Pangenomic Health Inc. |
Carasquero, Francisco Kent
4 - Director of Issuer
Holder: ETC3 Holdings Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
400,000 | ||
| Filed 2024-02-23 17:45 Tx date 2024-02-15 |
$NARA
Pangenomic Health Inc. |
Carasquero, Francisco Kent
4 - Director of Issuer
Holder: ETC3 Holdings Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-02-23 17:45 Tx date 2024-02-15 |
$NARA
Pangenomic Health Inc. |
Carasquero, Francisco Kent
4 - Director of Issuer
Holder: ETC3 Holdings Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
240,000 | ||
| Filed 2024-02-23 17:44 Tx date 2024-02-15 |
$NARA
Pangenomic Health Inc. |
Carasquero, Francisco Kent
4 - Director of Issuer
Holder: Stanlark Ventures Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
660,000 | ||
| Filed 2024-02-23 17:42 Tx date 2024-02-15 |
$NARA
Pangenomic Health Inc. |
Carasquero, Francisco Kent
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
634,978 |